Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1996-2-21
|
| pubmed:abstractText |
We have previously reported that recombinant human granulocyte colony-stimulating factor was well tolerated and resulted in sustained neutrophilia and improvement of neutrophil functions in newborn infants with presumed sepsis. We now report a 2-year follow-up on 21 of the initial cohort of 28 patients. Treatment with recombinant human granulocyte colony-stimulating factor in neonates with presumed sepsis was not associated with any long-term adverse hematologic, immunologic, or developmental effects.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0022-3476
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
128
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
135-7
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:8551404-Blood Cell Count,
pubmed-meshheading:8551404-Child Development,
pubmed-meshheading:8551404-Follow-Up Studies,
pubmed-meshheading:8551404-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:8551404-Humans,
pubmed-meshheading:8551404-Immunoglobulins,
pubmed-meshheading:8551404-Infant,
pubmed-meshheading:8551404-Infant, Newborn,
pubmed-meshheading:8551404-Recombinant Proteins,
pubmed-meshheading:8551404-Sepsis,
pubmed-meshheading:8551404-Treatment Outcome
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life.
|
| pubmed:affiliation |
Division of Hematology/Oncology, Children's Hospital of Orange County, Orange, California 92668, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|